John A. Zaia, MD, of Beckman Research Institute of City of Hope This year marks the 35th commemoration of World AIDS Day, a global event that aims to end human immunodeficiency virus (HIV) related stigma, honor people lost to the disease, and reaffirm the commitment to ensuring HIV is no longer a public health threat. … Continue reading CIRM Joins World AIDS Day Campaign, Commits $104 Million for HIV Research
Empowering Diversity, Equity, and Inclusion: A Week at the SACNAS National Diversity in STEM Conference
When I joined the California Institute for Regenerative Medicine (CIRM) as the new Community Outreach Manager, I was drawn to the Agency’s dedication to diversity, equity, and inclusion (DEI). Some DEI achievements include: Requiring plans for inclusion of diverse or underserved demographic groups in CIRM-funded clinical trials Providing valuable educational opportunities in regenerative medicine for … Continue reading Empowering Diversity, Equity, and Inclusion: A Week at the SACNAS National Diversity in STEM Conference
Upcoming Funding Opportunity: ReMIND-L Awards
The California Institute for Regenerative Medicine (CIRM) is pleased to announce ReMIND-L, the first funding opportunity under CIRM’s ReMIND Program – a new discovery stage initiative supporting foundational research in the study of neuropsychiatric diseases. Applications are due March 5, 2024 by 2:00 p.m. PST. Applications will be available mid-December 2023 but no later than two months … Continue reading Upcoming Funding Opportunity: ReMIND-L Awards
CIRM invests more than $42 million in translational-stage research
South San Francisco, CA, Oct. 27, 2023– The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $42.1 million to fund various translational research — from treating brain cancers and salivary gland conditions to advancing a therapy for a rare metabolic disease. The goal of CIRM’s Translational program is … Continue reading CIRM invests more than $42 million in translational-stage research
CIRM-Funded Program Targeting Rare Pediatric Disease Announces FDA Acceptance of Biologics License Application with Priority Review
South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institute dedicated to regenerative medicine, would like to congratulate Rocket Pharmaceuticals, Inc, a leading late-stage biotechnology company, on receiving U.S. FDA acceptance of the Biologics License Application (BLA) and Priority Review for RP-L201 (marnetegragene autotemcel), a lentiviral vector (LV)-based gene … Continue reading CIRM-Funded Program Targeting Rare Pediatric Disease Announces FDA Acceptance of Biologics License Application with Priority Review
CIRM brings together experts in the 6th annual Alpha Clinics Network Symposium at UC Irvine
The California Institute for Regenerative Medicine (CIRM) Alpha Clinics network specializes in delivering stem and gene cell clinical trials to patients. The key to the network’s success is the ability to foster partnerships with patients, medical providers, and clinical trial sponsors. The CIRM Alpha Clinics Network consists of nine leading medical centers throughout California. Every … Continue reading CIRM brings together experts in the 6th annual Alpha Clinics Network Symposium at UC Irvine
CIRM approves new plan to invest $110 million into basic research in neuropsychiatric diseases
The California Institute for Regenerative Medicine, the world’s largest institute dedicated to regenerative medicine, announced its approval of a new program called ReMIND at the September Independent Citizens Oversight Committee (ICOC) meeting that will eventually award up to $110 million to advance basic research in neuropsychiatric diseases—one of the largest investments of its kind in … Continue reading CIRM approves new plan to invest $110 million into basic research in neuropsychiatric diseases
CIRM invests nearly $44 million to advance regenerative medicine research and manufacturing in California
Novoglia, Inc. was awarded a $1.4 million award to support the development of a cell therapy for the treatment of ALSP. Pictured are Novoglia, Inc. co-founders Sunil Gandhi, PhD, Robert Spitale, PhD, and Mathew Blurton-Jones, PhD. September 29, 2023 South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution … Continue reading CIRM invests nearly $44 million to advance regenerative medicine research and manufacturing in California
CIRM Joins #GoGold Childhood Cancer Awareness Campaign
Photo courtesy of Stanford Medicine September is Childhood Cancer Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #GoGold to raise awareness about childhood cancers and highlight our commitment to funding childhood cancer research. The Impact of Childhood Cancer Cancer remains the number one cause of death by disease for … Continue reading CIRM Joins #GoGold Childhood Cancer Awareness Campaign
CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow
More than 110 student scientists from around California showcased their enthusiasm, passion and “spark” for regenerative medicine and stem cell research at this year’s annual CIRM SPARK Conference. Hosted by Cedars Sinai from Aug. 8-9 in Los Angeles, this year’s event showcased the extraordinary potential of high school students who are poised to become the … Continue reading CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow
The Stem Cellar 